What topics and trends defined most-cited Epilepsy research and treatment research in the Class of 2026?
Drug-resistant epilepsy, seizure detection, and EEG-based analytics anchor the Class of 2026 epilepsy cohort, alongside long-term monitoring, surgical resection, and antiseizure medication themes. From Class of 2025 to 2026, long-term EEG monitoring, topiramate, valproate, and seizure prediction rose sharply while drug-resistant epilepsy and focal seizures receded among top-cited work.
At a glance
- Field
- Epilepsy research and treatment
- Cohort label
- Class of 2026 (2024 publications)
- Papers analyzed
- 7,354
- Papers ranked
- 20
- Top topics in ranked papers
- Drug-resistant epilepsy, seizure detection, EEG classification, long-term EEG monitoring, valproate
- Publication window
- Jan 1, 2024 – Dec 31, 2024
- Eligibility
- Research articles; reviews excluded
- Citation window
- 18 months post-publication
- 18m citation range
- 27–66
- Data source
- OpenAlex · Retrieved Jul 2026
- License
- CC BY 4.0
Rankings
20 papers ranked by 18-month citation count
Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy
JAMA Neurology202410.1001/jamaneurol.2024.0258
Epileptic seizure prediction via multidimensional transformer and recurrent neural network fusion
Journal of Translational Medicine202410.1186/s12967-024-05678-7
Pathophysiology, Diagnosis, Prognosis, and Prevention of Poststroke Epilepsy
Neurology202410.1212/wnl.0000000000209450
Determination of oxidative stress level and some antioxidant activities in refractory epilepsy patients
Scientific Reports202410.1038/s41598-024-57224-6
Spike ripples localize the epileptogenic zone best: an international intracranial study
Brain202410.1093/brain/awae037
Development and validation of an automatic machine learning model to predict abnormal increase of transaminase in valproic acid-treated epilepsy
Archives of Toxicology202410.1007/s00204-024-03803-5
Guidelines for Specialized Epilepsy Centers
Neurology202410.1212/wnl.0000000000208087
A scheme combining feature fusion and hybrid deep learning models for epileptic seizure detection and prediction
Scientific Reports202410.1038/s41598-024-67855-4
Refining management strategies for Lennox–Gastaut syndrome: Updated algorithms and practical approaches
Epilepsia Open202410.1002/epi4.13075
Residual and bidirectional LSTM for epileptic seizure detection
Frontiers in Computational Neuroscience202410.3389/fncom.2024.1415967
Over‐ and underreporting of seizures: How big is the problem?
Epilepsia202410.1111/epi.17930
Global, regional, and national time trends in the burden of epilepsy, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study
Frontiers in Neurology202410.3389/fneur.2024.1418926
Antiseizure medication use during pregnancy and children’s neurodevelopmental outcomes
Nature Communications202410.1038/s41467-024-53813-1
The fasciola cinereum of the hippocampal tail as an interventional target in epilepsy
Nature Medicine202410.1038/s41591-024-02924-9
<scp>SzCORE</scp>: Seizure Community Open‐Source Research Evaluation framework for the validation of <scp>electroencephalography</scp>‐based automated seizure detection algorithms
Epilepsia202410.1111/epi.18113
Risk of Perinatal and Maternal Morbidity and Mortality Among Pregnant Women With Epilepsy
JAMA Neurology202410.1001/jamaneurol.2024.2375
Hippocampal network activity forecasts epileptic seizures
Nature Medicine202410.1038/s41591-024-03149-6
Ictal Involvement of the Pulvinar and the Anterior Nucleus of the Thalamus in Patients With Refractory Epilepsy
Neurology202410.1212/wnl.0000000000210039
Long-term neuropsychological trajectories in children with epilepsy: does surgery halt decline?
Brain202410.1093/brain/awae121
Multi‐omics technologies and molecular biomarkers in brain tumor‐related epilepsy
CNS Neuroscience & Therapeutics202410.1111/cns.14717
Topic trends
Dominant research themes and year-over-year shifts in Epilepsy research and treatment
What Topics Define the Class of 2026?
The word cloud of canonical topics across the 50 highest 18-month-cited papers in epilepsy research and treatment reveals a field organized around refractory disease management, computational seizure analytics, and therapeutic decision-making rather than generic epidemiology labels. Drug-resistant epilepsy (DRE) remains the most frequently mentioned informative topic, appearing in 8 of 50 papers (normalized frequency 0.16), followed by seizure detection (6 papers, 0.12). A second tier clusters EEG-centric and monitoring themes—EEG classification, long-term EEG monitoring, and drug-resistant focal epilepsy each appear in 5 papers (0.10)—alongside surgical resection, valproate, topiramate, seizure prediction, and developmental and epileptic encephalopathy (4 papers each, 0.08). Larger type further highlights convolutional neural networks, attention mechanisms, hybrid deep learning models, intracranial EEG, epilepsy surgery, presurgical evaluation, and genotype–phenotype correlation, signaling that influential 2024 publications increasingly pair clinical refractory-epilepsy cohorts with machine-learning pipelines for detection, classification, and prediction. Antiseizure medication topics—including clobazam, lamotrigine, carbamazepine, and cenobamate—appear alongside centromedian nucleus stimulation and electrode localization, suggesting that high-impact work spans pharmacotherapy safety, neuromodulation targets, and surgical candidacy rather than a single modality.

How Did Topics Shift from the Class of 2025 to the Class of 2026?
Comparing normalized concept frequencies between the Class of 2025 (2023 publications) and Class of 2026 (2024 publications) cohorts shows a rebalancing of early-high-impact epilepsy research priorities. Drug-resistant epilepsy remained the leading theme but declined from a normalized frequency of 0.28 to 0.16 (−0.12), indicating that while refractory disease still anchors the leaderboard, other topics gained relative prominence. Focal seizures fell sharply (−0.10), and seizure detection (−0.06), surgical resection (−0.06), and Dravet syndrome (−0.06) also receded among the most-cited concept set. Conversely, long-term EEG monitoring rose from 0.02 to 0.10 (+0.08), and topiramate, valproate, and seizure prediction each climbed to 0.08 (+0.06–0.08 from near-zero baselines). Drug-resistant focal epilepsy, EEG classification, developmental and epileptic encephalopathy, electrode localization, and lamotrigine showed additional gains. The topic evolution card underscores that Class of 2026 bars extend furthest for long-term EEG monitoring, drug-resistant focal epilepsy, EEG classification, and several antiseizure medication themes—topics aligned with extended monitoring protocols, ML-assisted EEG analytics, and medication-outcome studies—while Class of 2025 led more strongly on broad DRE and seizure-detection framing. Together, these shifts suggest that the most-cited 2024 papers emphasize precision monitoring, named antiseizure regimens, and focal refractory subtypes over generalized seizure-detection and legacy focal-seizure narratives.

Methodology
PRI identifies high-impact research using a transparent, topic-agnostic framework applied consistently across scientific domains. Bibliographic records are drawn from OpenAlex, including publication dates, citation relationships, and document types.
This ranking covers the Class of 2026 cohort: journal articles published in 2024. Reviews and other non-article document types are excluded to ensure comparability.
Research impact is quantified with an 18-month post-publication citation window—the number of citing works published within 18 months of each paper's publication date. This metric captures early impact while controlling for publication age.
An LLM-based relevance classifier then reviews each candidate's title and abstract to confirm substantive alignment with the target domain. Only papers classified as relevant appear in the final ranking.
Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Epilepsy research and treatment Papers, Class of 2026. https://pri.pepkio.com/top-papers/epilepsy-research-and-treatment/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
